Skip to main content
Journal cover image

Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy?

Publication ,  Journal Article
Milano, MT; Salama, JK; Chmura, SJ
Published in: J Natl Cancer Inst
June 8, 2023

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

June 8, 2023

Volume

115

Issue

6

Start / End Page

605 / 607

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Radiation Oncology
  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Humans
  • ErbB Receptors
  • Carcinoma, Non-Small-Cell Lung
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Milano, M. T., Salama, J. K., & Chmura, S. J. (2023). Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy? J Natl Cancer Inst, 115(6), 605–607. https://doi.org/10.1093/jnci/djac016
Milano, Michael T., Joseph K. Salama, and Steven J. Chmura. “Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy?J Natl Cancer Inst 115, no. 6 (June 8, 2023): 605–7. https://doi.org/10.1093/jnci/djac016.
Milano, Michael T., et al. “Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy?J Natl Cancer Inst, vol. 115, no. 6, June 2023, pp. 605–07. Pubmed, doi:10.1093/jnci/djac016.
Journal cover image

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

June 8, 2023

Volume

115

Issue

6

Start / End Page

605 / 607

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Radiation Oncology
  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Humans
  • ErbB Receptors
  • Carcinoma, Non-Small-Cell Lung
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis